Patents Assigned to ILiAD Biotechnologies, LLC
  • Treatment and prevention of neuropathology associated with neurodegenerative diseases
    Patent number: 11986499
    Abstract: Administering a live, attenuated Bordetella pertussis-based vaccine to a subject at risk for developing a neurodegenerative disease featuring A? brain plaques can prevent or reduce the amount of A? brain plaques that would have developed in the subject without such treatment.
    Type: Grant
    Filed: November 16, 2021
    Date of Patent: May 21, 2024
    Assignee: ILiAD Biotechnologies, LLC
    Inventors: Keith Rubin, Steven Glazer, Marina Lynch, Kingston Mills